Retinal Tissue Engineering: Regenerative and Drug Delivery Approaches.
Retinal tissue engineering
drug delivery
regeneration
retinal degenerative diseases
retinal diseases
retinal pigment epithelium
Journal
Current stem cell research & therapy
ISSN: 2212-3946
Titre abrégé: Curr Stem Cell Res Ther
Pays: United Arab Emirates
ID NLM: 101272517
Informations de publication
Date de publication:
2023
2023
Historique:
received:
02
02
2022
revised:
05
04
2022
accepted:
11
04
2022
medline:
22
5
2023
pubmed:
24
6
2022
entrez:
23
6
2022
Statut:
ppublish
Résumé
In recent decades, the improvement of photoreceptor-cell transplantation has been used as an effective therapeutic approach to treat retinal degenerative diseases. In this review, the effect of different factors on the differentiation process and stem cells toward photoreceptors along with cell viability, morphology, migration, adhesion, proliferation, and differentiation efficiency is discussed. Scientists are researching to better recognize the reasons for retinal degeneration, as well as discovering novel therapeutic methods to restore lost vision. In this field, several procedures and treatments in the implantation of stem cells-derived retinal cells have been explored for clinical trials. However, the number of these clinical trials is too small to draw sound decisions about whether stem-cell therapies can offer a cure for retinal diseases. Nevertheless, future research directions have started for patients affected by retinal degeneration and promising findings have been obtained.
Identifiants
pubmed: 35733318
pii: CSCR-EPUB-124680
doi: 10.2174/1574888X17666220621153508
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
608-640Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.